Shares of Omada Health, Inc. (NASDAQ:OMDA - Get Free Report) have received a consensus rating of "Moderate Buy" from the fourteen research firms that are currently covering the company, Marketbeat reports. One analyst has rated the stock with a sell rating, two have issued a hold rating and eleven have given a buy rating to the company. The average 12 month price target among brokers that have covered the stock in the last year is $24.75.
Several research firms recently commented on OMDA. Canaccord Genuity Group raised their price objective on shares of Omada Health from $24.00 to $28.00 and gave the stock a "buy" rating in a report on Tuesday, July 21st. BTIG Research started coverage on Omada Health in a research report on Friday, July 17th. They set a "buy" rating and a $30.00 target price on the stock. Needham & Company LLC reaffirmed a "buy" rating and issued a $28.00 price target on shares of Omada Health in a report on Friday, May 8th. Evercore reiterated an "outperform" rating and issued a $20.00 price target on shares of Omada Health in a research report on Friday, May 8th. Finally, Citigroup reissued an "outperform" rating on shares of Omada Health in a report on Monday, July 20th.
Get Our Latest Stock Analysis on Omada Health
Insider Activity
In related news, CEO Sean P. Duffy sold 12,944 shares of the business's stock in a transaction that occurred on Monday, August 3rd. The shares were sold at an average price of $20.40, for a total transaction of $264,057.60. Following the completion of the transaction, the chief executive officer owned 411,861 shares of the company's stock, valued at approximately $8,401,964.40. The trade was a 3.05% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CAO Craig Gracey sold 2,083 shares of the company's stock in a transaction that occurred on Monday, June 29th. The stock was sold at an average price of $21.00, for a total transaction of $43,743.00. Following the sale, the chief accounting officer directly owned 858 shares in the company, valued at $18,018. This trade represents a 70.83% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 206,406 shares of company stock worth $4,191,483 over the last ninety days. Company insiders own 6.38% of the company's stock.
Institutional Inflows and Outflows
Institutional investors have recently made changes to their positions in the company. Perceptive Advisors LLC bought a new position in shares of Omada Health in the 2nd quarter worth $44,402,000. Millennium Management LLC grew its position in Omada Health by 1,195.0% in the fourth quarter. Millennium Management LLC now owns 2,272,168 shares of the company's stock worth $35,855,000 after acquiring an additional 2,096,705 shares in the last quarter. Loomis Sayles & Co. L P grew its position in Omada Health by 23.0% in the fourth quarter. Loomis Sayles & Co. L P now owns 1,855,721 shares of the company's stock worth $29,283,000 after acquiring an additional 346,588 shares in the last quarter. Jefferies Financial Group Inc. bought a new position in Omada Health in the fourth quarter valued at $16,948,000. Finally, BIT Capital GmbH raised its position in Omada Health by 52.4% during the fourth quarter. BIT Capital GmbH now owns 940,238 shares of the company's stock valued at $14,837,000 after purchasing an additional 323,365 shares in the last quarter.
Omada Health Stock Performance
Shares of Omada Health stock opened at $19.11 on Thursday. Omada Health has a 52-week low of $10.28 and a 52-week high of $26.92. The stock's 50-day simple moving average is $20.21 and its 200 day simple moving average is $16.12. The stock has a market capitalization of $1.14 billion, a P/E ratio of -70.78 and a beta of 1.73.
Omada Health (NASDAQ:OMDA - Get Free Report) last posted its earnings results on Thursday, May 7th. The company reported ($0.05) earnings per share for the quarter, topping the consensus estimate of ($0.08) by $0.03. The firm had revenue of $78.05 million during the quarter. Omada Health had a negative net margin of 2.22% and a negative return on equity of 1.82%. Equities research analysts forecast that Omada Health will post -0.01 EPS for the current fiscal year.
About Omada Health
(
Get Free Report)
Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company's platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.
In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Omada Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Omada Health wasn't on the list.
While Omada Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries.
"Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
